Clinical Trial Update: Ethosuximide to Treat IBS [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ethosuximide for irritable bowel syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Ethosuximide (ethosuximide)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED